Zusammenfassung
Der Begriff „Lebensqualität“ ist derzeit ein häufig gebrauchtes Schlagwort in gesundheitspolitischen Diskussionen sowie in medizinischen Publikationen. Als eigenständiger Begriff im Index Medicus findet er sich erst seit 1977. Vor allem durch die Veröffentlichungen von Croog et al. (1986), in denen die Effekte antihypertensiver Therapie auf die Lebensqualität („quality of life“) beschrieben wurden, gewannen diesbezügliche Untersuchungen zunehmend an Bedeutung, was sich an der Vielzahl wissenschaftlicher Publikationen und Kongreßthemen zu diesem Begriff belegen läßt (Tüchler u. Lutz 1991; Bullinger et al. 1991; Vaitl 1991 a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Affleck G, Tennen H, Croog S, Levine S (1987) Causal attribution, perceived benefits, and morbidity after a heart attack: an 8-year study. J Consult Clin Psychol 55:29–35
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn., revised. (Deutsche Fassung (1989): Diagnostische Kriterien und Differentialdiagnosen des diagnostischen und statistischen Manuals psychischer Störungen DSM-III-R. Beltz, Weinheim Basel)
Amdisen A, Hildebrandt J (1988) Use of lithium in the medical ill. Psychother Psychosom 49:103–119
Arlock P, Gullberg Bo, Olsson S-OR (1978) Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine. Naunyn-Schmiedeberg’s Arch Pharmacol 304:27–36
Aronson MD, Hafez H (1986) A case of trazodone-induced ventricular tachycardia. J Clin Psychiatry 47:388–389
Austin LS, Arana GW, Ballenger JC (1990) Rapid response of patients simultaneously treated with lithium and nortriptyline. J Clin Psychiatry 51:124–125
Beck AT, Steer RA, Garbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77–100
Becker R, Katz J, Polonius M-J, Speidel H (1982) (eds) Psychopathological and neurological dysfunctions following open-heart surgery. Springer, Berlin Heidelberg New York
Bigger JT, Giardina EGV, Perel JM et al. (1977) Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med 296:206–208
Bond W (1986) Psychiatric indications for clonidinde: the neuropharmacologic and clinical basis. J Clin Psychopharmacol 6:81–87
Borchard U (1989) Klinische Pharmakologie der β-Rezeptorenblocker. Aesopus, Basel
Bowers WA (1990) Treatment of depressed in-patients: cognitive therapy plus medication, relaxation plus medication and medication alone. Br J Psychiatry 156:73–78
Buff DD, Brenner R, Kirtane SS, Gilboa R (1991) Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry 52:174–176
Bullinger M, Ludwig M, Steinbüchel N von (1991) (Hrsg) Lebensqualität bei kardiovaskulären Erkrankungen. Hogrefe, Göttingen Toronto Zürich
Burvill PW (1990) The epidemiology of psychological disorders in general medical settings. In: Sartorius N, Goldberg D, Girolamo G de, Costa e Silva JA, Lecrubier Y, Wittchen H-U (eds) Psychological disorders in general medical settings. Hogrefe & Huber, Toronto Lewi-ston, NY, Bern
Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Jaffe A (1987) Major depressive disorder in coronary artery disease. Am J Cardiol 60:1273–1275
Carney RM, Rich MW, Freedland KE et al. (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627–633
Cooper JE (1990) The classification of mental disorders for use in general medical settings. In: Sartorius N, Goldberg D, Girolamo G de, Coste e Silva JA, Lecrubier Y, Wittchen H-U (eds) Psychological disorders in general medical settings. Hogrefe & Huber, Toront Lewi-ston, NY, Bern
Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins D, Klerman GL, Williams GH (1986) The effects of antihypertensive therapy on the quality of life. N Engl J Med 314:1657–1664
Dalack GW, Roose SP (1990) Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 51 [Suppl]:4–9
Dietch JT, Fine M (1990) The effect of nortriptyline in elderly patients with cardiac conduction disease. J Clin Psychiatry 51:65–67
Eisendrath SJ, Sweeney MA (1987) Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations. Am J Psychiatry 144:506–507
Eriksson J (1988) Psychosomatic aspects of coronary artery bypass graft surgery. Acta Psychiatr Scand 77 [Suppl]:106 pp
Fabre LF, Scharf MB, Itil TM (1991) Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study. J Clin Psychiatry 52 [Suppl]: 62–67
Fava GA, Molnar G (1987) Criteria for diagnosing depression in the setting of medical disease. Psychother Psychosom 48:21–25
Fava GA, Sonino N, Wise TN (1988) Management of depression in medical patients. Psychother Psychosom 49:81–102
Fayer SA (1986) Torsades de pointes ventricular tachyarrhythmia associated with haloperidol. J Clin Psychopharmacol 6:375–376
Fedoroff JP, Lipsey JR, Starkstein SE, Forrester A, Price TR, Robinson RG (1991) Pheno-menological comparisons of major depression following stroke, myocardial infarction or spinal cord lesions. J Affective Disord 22:83–89
Fogel BS (1990) Major depression versus organic mood disorder: a questionalbe distinction. J Clin Psychiatry 51:53–56
Freeman AM, Fleece L, Folks DG, Sokol RS, Hall KR, Pacifico AD, McGiffin DC, Kirklin JK, Zorn GL, Karp RB (1986) Alprazolam treatment of postcoronary bypass anxiety and depression. J Clin Psychopharmacol 6:39–41
Friedman M, Rosenman RH (1974) Type A behaviour and your heart. Knopf, New York
Friedman M, Thoresen CE, Gill JJ, Powell LH, Ulmer D, Thompson L, Price VA, Rabin D, Breall WS, Dixon T, Levy R, Bourg E (1984) Alteration of type A behavior and reduction in cardiac recurrences in postmyocardial infarction patients. Am Heart J 108:237–248
Glass RM (1985) Situational and neurotic-reactive depression. Arch Gen Psychiatry 42:1126–1127
Glassmann AH, Bigger JT Jr (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review. Arch Gen Psychiatry 38:815–820
Goldman LS, Alexander RC, Luchins DJ (1986) Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects. J Clin Psychiatry 47:225–229
Griffin SJ, Friedman MJ (1986) Depressive symptoms in propranolol users. J Clin Psychiatry 47:453–457
Günthner A, Wehner-Caroli J, Haasis R, Seipel L, Heimann H (1991) Effekte von Enalapril und Digitoxin bei Patienten mit Herzinsuffizienz NYHA II auf die Lebensqualität. Z Kar-diol 80 [Suppl 6]:71
Gundle MJ, Reeves BR, Tate S, Kraft D, McLaurin LP (1980) Psychosocial outcome after coronary artery surgery. Am J Psychiatry 137:1591–1594
Hackl H (1988) Seltenes Auftreten des tödlichen Myokardinfarkts bei Patienten psychiatrischer Abteilungen. Herz Kreisl 20:406–410
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hasford J (1991) Kriterium Lebensqualität. In: Tüchler H, Lutz D (Hrsg) Lebensqualität und Krankheit. Deutscher Ärzte-Verlag, Köln, S 25–32
Herrmann C, Scholz K-H, Kreuzer H (1991) Psychologischs Screening von Patienten einer kardiologischen Akutklinik mit einer deutschen Fassung der „Hospital Anxiety and Depression“ (HAD)-Skala. Psychother Psychosom Med Psychol 41:83–92
Hui WKK, Mitchell LB, Kavanagh KM, Gillis AM, Wyse DG, Manyari DE, Duff HJ (1990) Melperone: electrophysiologic and antiarrhythmic activity in humans. J Cardiovasc Pharmacol 15:144–149
Isles LJ, Orrell MW (1991) Secondary mania after openheart surgery. Br J Psychiatry 159:280–282
Jefferson JW (1989) Cardiovascular effects and toxicity of anxiolytics and antidepressants. J Clin Psychiatry 50:368–378
Katon W, Sullivan M (1990) Depression and chronic medical illness. J Clin Psychiatry 51 [Suppl]:3–14
Kay J, Bienenfeld D, Slomowitz M et al. (1991) Use of tricyclic antidepressants in recipients of heart transplants. Psychosomatics 32:165–170
Keitner GI, Ryan CE, Miller IW, Kohn R, Epstein NB (1991) 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). Am J Psychiatry 148:345–350
Korff M von, Shapiro S, Burke JD, Teitlebaum M, Sinner EA, German P, Turner RW, Klein L, Burns B (1987) Anxiety and depression in a primary care clinic. Arch Gen Psychiatry 44:152–156
Kushnir SL (1986) Lithium-antidepressant combinations in the treatment of depressed physically ill geriatric patients. Am J Psychiatry 143:378–379
Lange-Braun P, Finger L, Lehmann H-U, Nunberger D, Hochrein H (1990) Psychosoziale Veränderungen nach Reanimation. Dtsch Med Wochenschr 115:203–207
Lown B, Desilva RA, Reich P, Murawski BJ (1980) Psychophysiologic factors in sudden cardiac death. Am J Psychiatry 137:1325–1335
Malzberg B (1937) Mortality among patients with involution melancholia. Am J Psychiatry 93:1231–1238
Margraf J, DeVries-Wehrhahn E, Sonnentag S (1991) Myokardinfarkt, funktionelle Herzbeschwerden und Paniksyndrom. Psychother Psychosom Med Psychol 41:31–34
Marschall H (1988) Epidemologische Erfassung hospitalisierter Depressiver. Darstellung einer klinischen depressiven Klientel anhand psychosozialer und kranheitsbezogener Daten. Med Dissertation, Universität Ulm
Mazza DL, Martin D, Spacavento L, Jacobsen J, Gibbs H (1986) Prevalence of anxiety disorders in patients with mitral valve prolapse. Am J Psychiatry 143:349–352
Mielke DH, Koepke RP, Phillips JH (1979) A controlled evaluation of a tetracyclic (maproti-line) and a tricyclic (imipramine) antidepressant and their effects on the heart. Curr Ther Res 25:738–742
Newman SC, Bland RC (1991) Suicide risk varies by subtype of affective disorder. Acta Psychiatr Scand 83:420–426
Ornish D (1991) Reversing heart disease. Century, London Sydney Auckland
Pecknold JC, Familamiri P, McClure DJ, Ehe R, Chang H (1985) Trimipramine and maproti-line: antidepressant, anxiolytic, and cardiotoxic comparison. J Clin Psychiatry 46:166–171
Perry S (1990) Combinging antidepressants and psychotherapy: rational and strategies. J Clin Psychiatry 51 [Suppl]:16–20
Pohl R, Bridges M, Rainey JM, Boudoulas H, Yeragani VK (1986) Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease. J Clin Psychopharmacol 6:380–381
Raith L, Hermes G, Stocksmeier U, Natus W (1981) Ausprägung depressiver Symptome bei chronisch Kranken und Gesunden. Psychother Med Psychol 31:20–29
Richardson HL, Graupner KI, Richardson ME (1966) Intramyocardial lesions in patients dying suddenly and unexpectedly. JAMA 195:114–120
Richardson HL, Graupner KI, Richardson ME (1966) Intramyocardial lesions in patients dying suddenly and unexpectedly. JAMA 195:114–120 Risch SC, Groom GP, Janowsky DS (1981) Interfaces of psychopharmacology and cardiology. J Clin Psychiatry 42:23–34 (part one) and 47–59 (part two)
Risch SC, Groom GP, Janowsky DS (1981) Interfaces of psychopharmacology and cardiology. J Clin Psychiatry 42:23–34 (part one) and 47–59 (part two)
Roose SP, Glassman AH, Giardina EGV (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 44:273–275
Roose SP, Glassman AH, Dalack GW (1989) Depression, heart disease, and tricyclic antidepressants. J Clin Psychiatry 50 [Suppl]:12–17
Roose SP, Dalack GW, Woodring S (1989) Death, depression, and heart disease. J Clin Psychiatry 52 [Suppl]:34–39
Rosenman RH, Chesney MA (1981) Psychological profiles and coronary heart disease. In: Kielholz P, Wiegenthale W, Taggart P, Zanchetti A (eds) Psychosomatic cardiovascular disorders — when and how to treat? Huber, Bern Stuttgart Vienna
Rosenman RH, Chesney MA (1982) Stress, type A behavior, and coronary disease. In: Gold-berger L, Breznitz S (eds) Handbook of stress: theoretical and clinical aspects. MacMillan, London, pp 547–565
Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M (1975) Coronary heart disease in the Western Collaborative Group Study. Final follow-up experience of 8,5 years. JAMA 234:872
Saravay SM, Steinberg MD, Weinschel B, Pollack S, Alovis N (1991) Psychological comorbidity and length of stay in the general hospital. Am J Psychiatry 148:324–329
Sartorius N, Goldberg D, Girolamo G de, Costa e Silva JA, Lecrubier Y, Wittchen H-U (1990) (eds) Psychological disorders in general medical settings. Hogrefe & Huber, Toronto Lewiston, NY, Bern
Schleifer SJ, Slater WR, Macari-Hinson MM, Coyle DA, Kahn M, Zucker HD, Gorlin R (1991) Digitalis and β-blocking agents: effects on depression following myocardial infarction. Am Heart J 121:1397–1402
Schulberg HC, Saul J, McClelland M (1985) Assessing depression in primary medical and psychiatric practices. Arch Gen Psychiatry 42:1164–1170
Shapiro PA (1991) Nortriptyline treatment of depressed cardiac transplant recipients. Am J Psychiatry 148:371–373
Siegrist J (1991) Die Erfassung subjektiver Gesundheit bei Patienten der Kardiologie. Prax Klin Verhaltensmed Rehab 4:250–254
Simons AD, Murphy GE, Levine JL, Wetzel RD (1986) Cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 43:43–48
Simpson WT (1977) Nature and incidence of unwanted effects with atenolol. Postgrad Med J 53:162
Skinner JE (1988) Brain involvement in cardiovascular disorders. In: Elbert T, Langosch W, Steptoes A, Vaitl D (eds) Behavioural medicine in cardiovascular disorders. John Wiley, New York, pp 229–253
Solomon L, Williamson P (1986) Verapamil in bipolar illness. Can J Psychiatry 31:442–443
Taylor CB, Hayward C (1990) Cardiovascular considerations in selection of anti-panic pharmacotherapy. J Psychiatr Res 24 [Suppl 2]:43–49
Tuchler H, Lutz D (1991) (Hrsg) Lebensqualität und Krankheit. Deutscher Ärzte-Verlag, Köln
Vaitl D (1991 a) Lebensqualität: Ein neues Forschungsfeld in der Inneren Medizin und Verhaltensmedizin. Prax Klin Verhaltensmed Rehab 4:245–249
Vaitl D (1991 b) Die medikamentöse Hypertoniebehandlung: Nebenwirkung und Lebensqualität. Prax Klin Verhaltensmed Rehab 4:255–265
Wallen J, Pincus HA, Goldman HH, Marcus SE (1987) Psychiatric consultations in short-term general hospitals. Arch Gen Psychiatry 44:163–168
Warrington SJ, Padgham C, Lader M (1989) The cardiovascular effects of antidepressants. Psychol Med [Monogr Suppl 16], University Press, Cambridge
Weeke A (1983) Todesursachen bei manisch-depressiven Patienten. In: Müller-Gerlinghausen B (Hrsg) Klinische Relevanz der Kardiotoxizität von Psychopharmaka. Pmi, Frankfurt/M Zürich, S 51–56
Wells KB, Golding JM, Burnam MA (1988) Psychiatric disorder in a sample of the general population with and without chronic medical condition. Am J Psychiatry 145:976–981
Weyerer S (1991) Relationships between physical and psychological disorders. In: Sartorius N, Goldberg D, Girolamo G de, Costa e Silva JA, Lecrubier Y, Wittchen H-U (eds) Psychological disorders in general medical settings. Hogrefe & Huber, Toronto Lewiston, NY, Bern, pp 34–46
Wheatley D, Bass C (1991) Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Br J Psychiatry 158:264–267
Winokur G, Black DW, Nasrallah A (1988) Depression secondary to other psychiatric disorders and medical illnesses. Am J Psychiatry 145:233–237
Wolfersdorf M (1988) Depression and Suizid bei körperlichen Krankheiten. Fortschr Med 106:269–274
Yates WR, Wesmer RB, Thompson R (1991) Organic mood disorder: a valid psychiatry consultation diagnosis? J Affective Disord 22:37–42
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Günthner, A., Szendey, I. (1994). Lebensqualität und Krankheitsverarbeitung bei Herzpatienten mit psychischen Störungen — ist eine Behandlung mit Antidepressiva sinnvoll?. In: Pflug, B. (eds) Differenzierte Therapie mit trizyklischen Antidepressiva. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77887-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-77887-2_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56129-3
Online ISBN: 978-3-642-77887-2
eBook Packages: Springer Book Archive